ETFsXtrackers MSCI USA Minimum Volatility UCITS ETF 1D
Xtrackers
Xtrackers MSCI USA Minimum Volatility UCITS ETF 1D
XMVU LSEDistributingIreland
Last close · EUR
58.40EUR
+0.01% · +€0.00
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
XMVUBase
- Fund charges
- Not publishedFee basis unverified
- Fund size
- Not published
- Return 1Y
- +15.2%
- Sharpe 3Y
- 0.85
- Volatility 1Y
- 8.9%annualised
- Holdings
- 174Fund holdings
Performance
Compare
- XMVU+15.2%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| XMVU | +7.0% | +9.6% | +15.4% | +15.5% | +15.2% | +42.8% | +48.7% |
| MSCI World | +0.4% | +4.9% | +10.8% | +16.3% | +15.9% | +75.5% | +71.2% |
| Gap to MSCI World | +6.6% | +4.7% | +4.6% | -0.8% | -0.7% | -32.7% | -22.5% |
Risk and return
Sharpe ratio · 3Y
0.85
Below MSCI World · 1.24- Return p.a.
- +11.7%
- Volatility
- 10.4%
- Max loss
- -14.7%Apr 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
XMVU
0.85
CAC 40
0.37
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 15.1%
- Holdings
- 174
- As of
- 1EXXONMOBIL HOLDINGS CORPUS30233Q10851.61%
- 2MICROSOFTUS59491810451.59%
- 3CHUBBCH00443287451.54%
- 4MOTOROLA SOLUTIONS INCUS62007630751.51%
- 5BERKSHIRE HATHAWAY INC CLASS BUS08467070261.50%
- 6AMPHENOL CORP CLASS AUS03209510171.50%
- 7MCKESSON CORPUS58155Q10311.48%
- 8JOHNSON & JOHNSONUS47816010461.47%
- 9WELLTOWERUS95040Q10401.46%
- 10VERTEX PHARMACEUTICALSUS92532F10031.46%
Countries
Classified 100.0%
United States98.3%
- Largest
- 98.3%United States
- Top 3
- 99.9%
- Effective number
- 1.01 / HHI
Market cap
Weight vs holdings
15.1%of the fund sits in the top 10 holdings
15.1%42.4%42.4%
WeightHoldings
40124
- Holdings 1-10
- Holdings 11-50
- Holdings 51-174
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.
